Invest. Engage. Save.

Rss

Speed Dating to Save Lives

Posted by: BIO Ventures for Global Health on 1/21/2010
Speed dating, or more accurately, partnering, is a distinct feature of nearly 35 meetings held each year by the biotech community. Partnering presents organizations with opportunities to meet companies and funders to discuss potential product development collaborations. It also allows a large number of these meetings to take place over a relatively short amount of time, saving participants significant resources. Meetings take place during 30-minute intervals in a massive room divided into cubicles, much the way speed dating works for single people. But rather than sitting down next to someone with whom you have nothing in common, organizations can use partnering software to research companies ahead of time, including the individual delegates who will be attending and information on products and licensing.

Last week, BIO Ventures for Global Health and the Biotechnology Industry Organization (BIO) announced the 2010 Partnering for Global Health Forum, which brings this concept of partnering to the intersection of biotech and global health. The Forum, which begins May 3rd in Chicago, will be co-located with BIO’s International Convention – the industry’s largest partnering event. A primary benefit of the co-location is that registered non-profit, academic, governmental, and non-governmental attendees will have full access to the BIO Convention’s Business Forum, the site of all the partnering activity. Past BIO Business Forums have been attended by more than 1,700 companies, and more than 50 percent of those companies were international.

In addition to three dedicated days of partnering from May 4-6, the Partnering for Global Health Forum will feature one day of high-impact panel discussions on May 3 that will showcase emerging market strategies, collaborative business models, and the impact of market-based incentives, all directed at encouraging industry investment to confront pressing needs for innovation and explore new avenues for progress.

Registration opens this week at www.pgh.bio.org. Will you find your match?

Representatives from for-profit institutions will have to register separately to attend the BIO Business Forum. Those already signed up for the BIO International Convention can attend the Partnering for Global Health Forum as an add-on to the Convention. For more information on registration fees, visit www.pgh.bio.org.

Jennifer Manganello is the Development Associate at BIO Ventures for Global Health.
Categories: Meetings
Create a trackback from your own site.
|   Blog Home

9 Comments

Apr 21 2010, 7:25 AM isis and osiris
Thats great, I never knew before this blog.
Jun 07 2010, 12:04 AM dating website uk
Thanks for posting this. I think this will greatly Now back to exercising! ha ha
Jun 18 2010, 4:55 AM singles dating
Wow, I never knew that Speed Dating to Save Lives.
Jun 22 2010, 8:12 AM Dissertation Help
I was just thinking about Speed Dating to Save Lives and you've really helped out. Thanks!
Jul 08 2010, 4:18 AM over40dating
Thanks for sharing a great post.This is really unique.
Jul 13 2010, 6:09 AM Over 50 Dating
Speed dating is rightly the order of the day, especially as time and managing resources are two prime concerns today!
Jul 16 2010, 8:47 AM 0nline dating
That's pretty interesting... That's great, I never thought about Speed Dating to Save Lives like that before.
Jul 16 2010, 8:54 AM 0nline dating
That's pretty interesting... That's great, I never thought about Speed Dating to Save Lives like that before.
Aug 25 2010, 2:44 AM forex online trading
This is really nice and interesting blog.I m glad to know. I admire the time and effort you put into your blog and detailed information you offer.
Leave A Comment

Please enter the CAPTCHA phrase above.
 

  
  

Recent Comments

by simon on The Most Important Hire in Global Health
"I'd like to comment on the fact that the term "cost-effective" vaccines is not meaningful, since cost-effectiveness always depends on the Willigness to Pay of a given coutnry (which WHO recommends to be 1-3xGDP per capita). E.g. while in UK a medicines/vaccine that has incremental cost-effectiveness ratio of 43,000-130,000 USD/QALY will be considered "cost-effective", it will not be the case in India where the threshold is 1-3xGDP=1,000-3,000 USD/QALY. It means that the same vaccine would need to be 43x cheaper in India than in UK to be cost-effective. I believe that the future of developing countries will depend on their ability to develop vaccines locally and sell them at local prices. I am currently involved in a research project in India which aims at understanding the challenges of entrepreneurship and its role in affordable healthcare in the future. Best regards " Read more »

by Mark H on Trademark of Innovation
"Often the pharmaceutical companies are seen as evil because they do not do enough to help the poor by giving away medicines or licence rights. But we must consider two things: 1 they are commecial companies and have legal obligations towards their shareholders i.e. their prime concern is making money 2 these companies invest a vastly greater amount of money in R&D than the government. As a result their R&D occasionally finds cures inadvertently for other diseases - even if they are not actively trying to create the right medicine. So how do you create an incentive for the most effective creator of new innovative cures whose primary goal is to make money (like all companies)? Well the answer seems obvious - reward them with tax benefits that would help push them above their competitors. Whilst you could argue that this would prevent the government from reaping the benefits (tax) you could also say that the competition created would drive innovation and spending in the private sector which would improve the economy. A win win win situation - pharmaceuticals, government, developing countries!" Read more »

by BIO Ventures for Global Health on Ready to Go
"Thanks so much for your interest, Trudy. We are not currently working with the Carter Center but we are interested in speaking with them to gain epidemiological information for our Global Health Primer, and so hope to be working together in the future. " Read more »

  

Tag Cloud